Atlas Trials

SGB Reduces the Incidence and Severity of CSA-AKI

Clinical trial NCT05652179 · COMPLETED

Trial details

NCT number
NCT05652179
Sponsor
Yangzhou University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Stellate Ganglion Block
Start date
2023-01-10
Primary completion
2023-12-01
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.